Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Technology Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

Bullboard (TSXV:ARCH)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Post by Riverfolkon Dec 30, 2021 8:41pm

ARCH - Intellectual Property

Intellectual Property MetaBlok was invented by Arch scientists Dr. Stephen Robbins, Dr. Donna Senger, Dr. Jennifer Rahn and their University of Calgary colleague, Dr. Paul Kubes. The inventors have ...more  
127
Post by C10H12N2on Dec 30, 2021 8:40pm

Yeah River. Those same talking point were debunked at CEO.CA

You were provided with a list of 22 Patents by Algernon which includes the Chronic Cough. I need not spam your coveted little message board with the particulars. You can catch up after the uplist to ...more  
138
Post by Riverfolkon Dec 30, 2021 8:37pm

ARCH - FULLY FUNDED PHASE III

Arch Biopartners’ Lead Drug LSALT Peptide to Enter the Canadian Treatments for COVID-19 (CATCO) Trial LSALT Peptide (LSALT) is a novel drug candidate that targets acute organ ...more  
146
Post by Riverfolkon Dec 30, 2021 8:34pm

Arch Biopartners - My Due Diligence (NEW)

Arch Biopartners Inc. is a clinical stage company focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact.  Arch is ...more  
168
Discussion
Post by Riverfolkon Dec 30, 2021 8:31pm

ARCH - Minister Copping

“The drug candidate from Arch Biopartners, which has the generic name LSALT peptide, was discovered by @UCalgary scientists about five years ago.” https://twitter.com/JasonCoppingAB/status ...more  
123
Post by Riverfolkon Dec 30, 2021 8:25pm

ARCH - Premier Kenney

Great to see this made-in-Alberta COVID-19 drug move ahead to national human trial. Once again, Alberta is flexing its research and innovation muscle! https://twitter.com/jkenney/status ...more  
127
Post by Riverfolkon Dec 30, 2021 8:22pm

ARCH - The Honourable Navdeep Bains

“As the world works toward an effective COVID-19 vaccine, we cannot lose sight of the importance of developing treatments to keep those stricken with the virus alive. Today’s contribution will support ...more  
129
Post by Riverfolkon Dec 30, 2021 8:21pm

Arch - The Honourable Franois-Philippe Champagne

“Our support for Arch Biopartners’ development of their COVID-19 treatment is an important part of our plan to rebuild Canada’s bio-manufacturing and life sciences sector. Today’s ...more  
111
Post by TheBearInTheWoodson Dec 30, 2021 7:43pm

Here is the reason AGN is .04

You can buy there main drug candidate over the counter in Japan lmao  https://bio-japan.net/Ifenprodil-10mg-tablets
136
Discussion
Comment by C10H12N2on Dec 30, 2021 6:14pm

RE:$3.35- Extremely Undervalued in Comparison to Phase II peers

I find it hilariously hypocritical that you would place Bellus Health in comparison to Arch and Arch is not chasing Chronic Cough. Yet an actual company with Chronic Cough in it's portfolio at ...more  
94
Discussion
Comment by stocksarefunon Dec 30, 2021 5:37pm

RE:Todays House Positions

So.. net -80k shares for anonymous today alone. Endless shares???
63
Discussion
Post by Riverfolkon Dec 30, 2021 5:06pm

MetaBlok - A Pathway to an unmet 20 billion market

Recently Arch Biopartners released a glimpse of the human data waiting on publication from a third party, that should be expected shortly. This data was further validated by CATCO when they sponored a ...more  
149
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities